MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
125 hedge funds and large institutions have $1.58B invested in Mirati Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 30 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5% less call options, than puts
Call options by funds: $33.1M | Put options by funds: $34.8M
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Holders
125
Holding in Top 10
6
Calls
$33.1M
Puts
$34.8M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$20M | |
| 3 | +$18.1M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$17.1M |
| 5 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$13.8M |
Top Sellers
| 1 | -$35.2M | |
| 2 | -$31.2M | |
| 3 | -$22.7M | |
| 4 |
DM
Deerfield Management
New York
|
-$21.6M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.86M |